With 10+ years of expertise, uBriGene delivers high-quality, tailored plasmid production services, driving innovation in the biopharma industry.
uBriGene has extensive experience in plasmid DNA production and development, delivering high-quality plasmid preparation service tailored to meet customer needs. Our expertise also extends to patented packaging plasmids, cloning plasmids, expression plasmids, and CRISPR plasmids for precise gene editing.
Extensive plasmid DNA production experience, delivering high quality while remaining cost-effective.
Access ready-for-use GMP-grade AAV plasmids and lentivirus plasmids
Plasmid construction begins with inserting a gene fragment into a vector backbone. Depending on the application, the plasmid elements can vary significantly, including prokaryotic expression, eukaryotic expression, viral vector packaging, etc. uBriGene’s plasmid construction experts provide full support for molecular cloning.
For discovery research, small-scale plasmid DNA preparation can be performed using commercial plasmid prep kits. For GMP plasmid manufacturing, cell banking is required after plasmid transformation. Fermentation is conducted in a well-controlled fermenter, and high-quality plasmids are then purified using chromatographic methods.
Plasmid development and production diagram.
Agarose gel image of eluted plasmids shows a high percentage of supercoiled forms.
Explore uBriGene’s robust GMP plasmid manufacturing process and testing capabilities.
Discover Lentivirus (LVV) production processes and testing.
Explore RNA drug development fundamentals and the vital role of IVT in manufacturing.
Discover our AAV manufacturing capabilities, scalable processes, testing platform.
In genetic engineering, plasmids are often used as vectors to transport genes of interest into target cells. Apart from their widespread applications in the field of scientific research, plasmids are also extensively employed in the development and production stages of various biopharmaceutical products, including recombinant protein drugs, vaccines, gene therapy drugs, CAR-T, and other therapy programs.
uBriGene provides flexible plasmid production from microgram (µg) quantities for research applications to gram (g) quantities for clinical or industrial applications. Production scale can be adjusted according to the project stage, intended application, required plasmid quantity, and manufacturing objectives. uBriGene supports both research-grade and GMP-grade plasmid DNA production.
The timeline for plasmid construction and production depends on the complexity and scale of the project. Research-grade plasmid production typically takes 2-3 weeks, while GMP plasmid production may take 8-12 weeks, depending on the requirements.
We implement stringent quality control (QC) measures throughout the plasmid production process, including DNA sequencing, restriction enzyme analysis, and endotoxin testing (upon request). A full suite of in-house plasmid QC release testing is available for plasmid DNA production. Each batch is produced under the same conditions to ensure consistency.
Yes, our regulatory affairs (RA) team provides support with regulatory documentation and compliance, assisting with submissions to agencies for plasmids intended for clinical use.
Our scaling process involves optimizing and validating the plasmid production method in a process development setting, followed by the implementation of GMP production protocols, including master cell banking, fermentation in controlled fermenters, and chromatographic purification to ensure high quality and regulatory compliance.
uBriGene supports custom plasmid design and construction for applications including prokaryotic and eukaryotic expression, viral vector packaging, and gene editing. The platform supports cloning plasmids, expression plasmids, packaging plasmids, and CRISPR plasmids for research, process development, and GMP manufacturing.
Yes. uBriGene provides GMP-grade plasmid DNA production for clinical and biopharmaceutical applications, supported by master cell banking, controlled fermentation, chromatographic purification, and in-house QC testing. Its GMP plasmid platform has delivered 300+ GMP plasmid batches across its manufacturing services.
uBriGene uses chromatographic downstream purification for plasmid DNA production. Its GMP plasmid platform uses a scalable purification process designed to remove process impurities and produce high-purity plasmid DNA, with the GMP platform reporting >90% supercoiled plasmid DNA and approximately 60% downstream recovery under its stated process conditions.
Extensive plasmid DNA production experience
Optimized plasmid preparation processes for high quality and high yield
100+ annual GMP plasmid production batches
